GlassScriptPhysician profile
Robert G Carlile
NPI 1508821794
$10,013.21
in general payments reported to CMS, 2019-2025
31 companies · $1,524 in 2025
The $1,524 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,944 · 2020: $833 · 2021: $1,722 · 2022: $1,272 · 2023: $1,414 · 2024: $1,304 · 2025: $1,524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,376 · Education: $741 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,376.45 |
| Education | $740.84 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $124.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $3,255.83 | 2019-2025 | Xtandi, Myrbetriq, Padcev |
| Neotract INC. | $989.37 | 2019-2020 | |
| Janssen Biotech, INC. | $943.89 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Pfizer INC. | $933.43 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $715.64 | 2023-2025 | Orgovyx, Gemtesa |
| Abbvie INC. | $710.39 | 2019-2024 | Lupron Depot, Teflaro |
| Boston Scientific Corporation | $640.81 | 2019-2023 | Ams 800 Artificial Urinary Sphincter |
| Amgen INC. | $328.08 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $275.07 | 2021-2025 | |
| Myovant Sciences INC. | $250.79 | 2021-2022 | |
| Allergan, INC. | $194.31 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $120.60 | 2019-2025 | Adstiladrin |
| Abbott Laboratories | $116.60 | 2023 | Infinity |
| Seagen INC. | $84.99 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $45.34 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $44.37 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $43.79 | 2021-2025 | Lynparza |
| Laborie Medical Technologies Corp. | $40.02 | 2025 | |
| Merck Sharp & Dohme LLC | $38.55 | 2020-2025 | Lynparza, Keytruda |
| Teleflex LLC | $34.64 | 2021-2022 | |
| Urogen Pharma, INC. | $28.23 | 2025 | |
| Procept Biorobotics Corporation | $28.11 | 2022 | |
| Emd Serono, INC. | $24.05 | 2022 | |
| Dendreon Pharmaceuticals LLC | $19.70 | 2019 | |
| Endo Pharmaceuticals INC. | $17.89 | 2021 | |
| Janssen Pharmaceuticals, INC | $16.95 | 2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.34 | 2022 | |
| Celgene Corporation | $14.76 | 2021 | |
| Olympus America INC. | $14.59 | 2019 | |
| Ethicon US, LLC | $13.93 | 2021 | |
| Lilly USA, LLC | $13.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Carlile listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.